Overview

Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
Impact of combined Lantus (insulin glargine) and Lyxumia(lixisenatide) on insulin secretion and gastric emptying
Phase:
Phase 2
Details
Lead Sponsor:
Profil Institut für Stoffwechselforschung GmbH
Collaborator:
Sanofi
Treatments:
Insulin
Insulin Glargine